A detailed history of Fmr LLC transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Fmr LLC holds 971 shares of NVCT stock, worth $6,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
971
Previous 435 123.22%
Holding current value
$6,544
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.98 - $8.25 $3,205 - $4,422
536 Added 123.22%
971 $6,000
Q1 2024

May 13, 2024

BUY
$6.69 - $11.0 $2,896 - $4,763
433 Added 21650.0%
435 $3,000
Q4 2023

Feb 13, 2024

SELL
$7.85 - $11.78 $39 - $58
-5 Reduced 71.43%
2 $0
Q3 2023

Nov 13, 2023

SELL
$12.89 - $16.29 $219 - $276
-17 Reduced 70.83%
7 $0
Q2 2023

Aug 11, 2023

BUY
$12.62 - $18.4 $302 - $441
24 New
24 $0

Others Institutions Holding NVCT

About Nuvectis Pharma, Inc.


  • Ticker NVCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,642,500
  • Market Cap $98.7M
  • Description
  • Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...
More about NVCT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.